Inventor · disambiguated record
Ruben Postel
Also filed as: POSTEL RUBEN
1 granted patent·24 pending applications·1 citations·filing 2019–2024
17Inventor score
Files withSAPREME TECH BV25
Top patents by PatentIndex Score
25 records- 0160US2025302983A1Saponin ConjugatesSAPREME TECH BV·Filed 2024·Application pending·0 cites
- 0257US12453782B2Antibody-oligonucleotide conjugateSAPREME TECH BV·Filed 2019·Granted Oct 28, 2025·1 cites·17 claims
- 0351US2025082759A1Compositions comprising therapeutic nucleic acid and targeted saponin for the treatment of muscle-wasting disordersSAPREME TECH BV·Filed 2022·Application pending·0 cites
- 0451US2025250564A2Compositions comprising therapeutic nucleic acid and saponin for the treatment of muscle-wasting disordersSAPREME TECH BV·Filed 2022·Application pending·0 cites
- 0549US2023302140A1Conjugate of a single domain antibody, a saponin and an effector molecule, pharmaceutical composition comprising the same, therapeutic use of said pharmaceutical compositionSAPREME TECH BV·Filed 2021·Application pending·0 cites
- 0649US2023277612A1Saponin derivatives for use in medicineSAPREME TECH BV·Filed 2021·Application pending·0 cites
- 0749US2025295800A1Conjugate of a single domain antibody, a saponin and an effector molecule, pharmaceutical composition comprising the same, therapeutic use of said pharmaceutical compositionSAPREME TECH BV·Filed 2022·Application pending·0 cites
- 0849US2023293708A1Conjugate of saponin and single-domain antibody, pharmaceutical composition comprising said conjugate, therapeutic use thereofSAPREME TECH BV·Filed 2021·Application pending·0 cites
- 0949US2023365617A1Saponin derivatives for use in medicineSAPREME TECH BV·Filed 2021·Application pending·0 cites
- 1048US2025057971A1Targeted saponin-nucleic acid conjugates for treatment of muscle wasting disordersSAPREME TECH BV·Filed 2022·Application pending·0 cites
- 1147US2023248844A1Combination comprising an adc or an aoc comprising a vhh, and a saponin or a ligand-saponin conjugateSAPREME TECH BV·Filed 2021·Application pending·0 cites
- 1245US2023270872A1Conjugate of saponin and single-domain antibody, pharmaceutical composition comprising said conjugate, therapeutic use thereofSAPREME TECH BV·Filed 2020·Application pending·0 cites
- 1345US2024307545A1Conjugate of saponin, oligonucleotide and galnacSAPREME TECH BV·Filed 2022·Application pending·0 cites
- 1445US2023277680A1Conjugate of a single domain antibody, a saponin and an effector molecule, pharmaceutical composition comprising the same, therapeutic use of said pharmaceutical compositionSAPREME TECH BV·Filed 2020·Application pending·0 cites
- 1544US2024115712A1Semicarbazone-based saponin conjugateSAPREME TECH BV·Filed 2022·Application pending·0 cites
- 1643US2024066045A1Semicarbazone-based saponin conjugateSAPREME TECH BV·Filed 2021·Application pending·0 cites
- 1742US2023256111A1Combination comprising an adc or an aoc comprising a vhh, and a saponin or a ligand-saponin conjugateSAPREME TECH BV·Filed 2020·Application pending·0 cites
- 1842US2024279684A1Cytosolic delivery of genome editing toolsSAPREME TECH BV·Filed 2022·Application pending·0 cites
- 1942US2023248845A1Combination of an antibody-drug conjugate and an antibody-saponin conjugateSAPREME TECH BV·Filed 2021·Application pending·0 cites
- 2042US2023293562A1Therapeutic combination of galnac-oligonucleotide conjugate and saponin, and uses thereofSAPREME TECH BV·Filed 2021·Application pending·0 cites
- 2142US2024115726A1Hydrazone-based saponin derivativesSAPREME TECH BV·Filed 2021·Application pending·0 cites
- 2241US2024327829A1Conjugate of saponin, oligonucleotide and galnacSAPREME TECH BV·Filed 2021·Application pending·0 cites
- 2340US2023263897A1Conjugate of galnac and saponin, therapeutic composition comprising said conjugate and a galnac-oligonucleotide conjugateSAPREME TECH BV·Filed 2021·Application pending·0 cites
- 2437US2023357310A1Saponin derivatives with improved therapeutic windowSAPREME TECH BV·Filed 2020·Application pending·0 cites
- 2532US2022249674A1Bioactive saponin linked to a functional moietySAPREME TECH BV·Filed 2020·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Ruben Postel files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →